Navigation Links


Pramlintide in Medical News

Use of Mealtime Pramlintide Added to Basal Insulin Showed Similar Improvements in Glycemic Control Compared to Rapid-Acting Insulin, With Lower Risk of Hypoglycemia and Without Weight Gain: Data Presented at ADA 2009

Additional Analyses Showed Pramlintide Improved Treatment Satisfaction and Quality of Life NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced data showing that the use of mealtime SYMLIN(R) (pramlintide acetate) injection improved gluc...

Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009

...:30 PM ET). Poster: "Clinical and Patient Reported Outcomes in Adults with Type 2 Diabetes on Basal Insulin Randomized to Addition of Mealtime pramlintide or Rapid-Acting Insulin" will be presented by Mark Peyrot, Ph.D. during a poster session on Saturday, June 6 from 11:30 AM - 1:30 PM CT (12:30 - 2:30 ...

Pipeline for New Obesity Therapies is Focus of New Report

...ide; Amylin/Lilly), exenatide LAR (Lilly/Amylin/Alkermes), exenatide + recombinant leptin (r-metHuLeptin; Amylin/Amgen), Symlin (pramlintide; Amylin), pramlintide + AC162352 (PYY 3-36; Amylin), liraglutide (NN2211; Novo Nordisk), albiglutide (GSK / Human Genome Science), PC-DAC:Exendin-4 (ConjuChem), Boc5 (SH-78...

Endocrinology Panel Examines Interplay Between Diabetes and Cardiovascular Disease in New Report

...his report: metformin, Januvia/Janumet (sitagliptin; Merck), Byetta (exenatide; Lilly/Amylin), exenatide LAR (Lilly/Amylin/Alkermes), Symlin (Amylin), pramlintide + leptin (Amylin/Amgen), Galvus (vildagliptin; Novartis), alogliptin (Takeda), saxagliptin (BMS/AZ), Redona (denagliptin; GSK), liraglutide (Novo Nord...

GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology

...ion and other meetings show that GlycoMark is particularly valuable in detecting underlying treatment effects of agents such as exenatide (Byetta) and pramlintide (Symlin) which were not revealed by the gold standard hemoglobin A1C test. These findings have important implications for patient care and pharmaceuti...

Pramlintide-A Boon to Restrain Fast Food Consumption

...g and the desire to eat high-fat foods and sweets. pramlintide is the synthetic form of amylin, a satiety hormone...the pancreas, which also produce insulin. pramlintide treatment reduces 24-hour caloric intake and meal ... partnership with insulin to regulate blood sugar. pramlintide is also under development as a potential drug for ...
Pramlintide in Medical Technology

Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society

...45 p.m. ET). 3. Poster 323-P: "Safety of 360 ug pramlintide BID treatment for up to 2 years" will be pres...g scale scores in obese subjects treated with pramlintide as monotherapy and in combination with oral w...ut Pramlintide/Metreleptin Combination Treatment pramlintide acetate is a synthetic analog of the natural hormo...

DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes

... Additional Studies Indicate GlycoMark May Be a More Effective Monitor Than Hemoglobin A1C of Exenatide, Sitagliptin, pramlintide and Prandial Insulin Therapies in Certain Diabetic Populations SAN FRANCISCO, June 7 /PRNewswire/ -- GlycoMark, Inc. announced today r...

Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity

...st that metreleptin may be an effective partner to pramlintide in the treatment of obesity. The full paper, pub... to the development of obesity treatments. About pramlintide and Metreleptin pramlintide is a synthetic analog of amylin, a neurohormone se...

Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007

...e presented by Jonathan Roth, Ph.D. on Monday, June 25 at 3:45 PM CT (4:45 PM ET). 6. Oral: "Sustained Weight Loss Following 1-y pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity" will be presented by Steven Smith, M.D. on Monday, June 25 at 5:30 PM CT...
Pramlintide in Biological News

FDA Approves New Drug to Treat Type I and Type II Diabetes

...es. Symlin should not be used if patients cannot tell when their blood sugar is low, have gastroparesis (slow stomach emptying), or are allergic to pramlintide acetate, metacresol, D-mannitol, acetic acid, or sodium acetate. Side effects associated with Symlin include but are not limited to nausea, vomitin...
Pramlintide in Biological Technology

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

...eptin was more than additive compared to that with pramlintide and metreleptin alone, a finding that was not obse...g eight treatment regimens: 1) placebo/placebo; 2) pramlintide 360 mcg/placebo; 3) metreleptin 5 mg/placebo; 4) pramlintide 180 mcg/metreleptin 2.5 mg; 5)...

Amylin Pharmaceuticals Reports Third Quarter Financial Results

...kground of metformin therapy. Obesity Program -- Completed enrollment of a phase 2B study to evaluate different dosing combinations of pramlintide and metreleptin. The objective of this dose-ranging study is to support dose selection for phase 3, and to guide the development of a deliv...

Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008

... a poster session on Monday, June 9 from 12:00 - 2:00 PM PT (3:00 - 5:00 PM ET). 2. Oral: "Enhanced Weight Loss Following Co-Administration of pramlintide with Sibutramine or Phentermine in Obese Subjects" will be presented by Louis Aronne, M.D. on Saturday, June 7 at 5:00 PM PT (8:00 PM ET). ...

Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes

...ion and other meetings show that GlycoMark is particularly valuable in detecting underlying treatment effects of agents such as exenatide (Byetta) and pramlintide (Symlin) which were not revealed by the gold standard hemoglobin A1C test. These findings have important implications for patient care and pharmaceuti...
Other TagsCantCantCantlastinlastinlastinshoeToneToneToneToneTone
(Date:12/15/2009)... Now that Physicians cannot bill Medicare for consultations how will ... explains how in easy to understand terms. , ... ... On January 1, 2010 Medicare will eliminate consultation codes. ... reimbursement when a patient is seen for a medical consultation, ...
(Date:12/15/2009)... as Henry Ford Health System Joins the influx of Healthcare ... ... Hazlet, N.J. (PRWEB) December 15, 2009 ... talent acquisition solutions , announced today that Henry Ford Health ... support its talent management needs. Henry Ford joins more than ...
(Date:12/15/2009)... new report titled, “Incontinence Devices Markets Worldwide.” The report ... and manage urinary incontinence. , ... ... to announce the release of a new report titled, “Incontinence ... for clinical devices used to treat and manage urinary incontinence., ...
(Date:12/15/2009)... DALLAS Dec. 15, 2009 UT Southwestern ... account to date of the unique observable characteristics ... aging syndrome. , The findings, reported online and ... of Clinical Endocrinology and Metabolism, suggest that ... be lumped together with those diagnosed with two ...
(Date:12/14/2009)... and NaturalFill™ revolutionary new liposuction and fat transfer treatments can ... all in one minimally invasive treatment. , ... ... AQUALIPO™ and NaturalFill™ can remove excess fat from the abdomen ... people slim down, reduce facial wrinkling and enhance lips all ...
Breaking Medicine News(10 mins):Health News:Medicare Eliminates Consultation Codes for Doctors 2Health News:iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems 2Health News:iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems 3Health News:iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems 4Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3
(Date:12/11/2009)... , Montreal, December 11, 2009 Canadian ... cancer. In the December 11 edition of the prestigious ... de Montral and the Universit de Sherbrooke explain how ... activity of cytokines, hormones that are culprits in cancer-prone ... people exposed to asbestos. , "Excessive cytokine activity ...
(Date:12/11/2009)... CORVALIS, ORFruit growers, profits have traditionally been ... climates where growing seasons can be short. ... developed varieties are being introduced that offer ... the offseasonresulting in economic bonuses for both ... new varieties of blackberry called "primocane-fruiting", which ...
(Date:12/11/2009)... roe of hake, lumpsucker and salmon is the best dietary ... by researchers at the University of Almera (UAL). The scientists ... found all of these contained high levels of these fatty ... now there had been no precise understanding of the nutritional ... of researchers from the UAL has now shown that this ...
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2DaVita com Provides Easy Recipes to Plan Your Fathers Day Dinner 49539 1DaVita com Provides Easy Recipes to Plan Your Fathers Day Dinner 49539 2DaVita com Provides Easy Recipes to Plan Your Fathers Day Dinner 49539 3Last Day of Special Olympics Minnesotas 2009 Summer Games 49537 1Last Day of Special Olympics Minnesotas 2009 Summer Games 49537 2Last Day of Special Olympics Minnesotas 2009 Summer Games 49537 3RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 1RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 2RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 3RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 4
Other Contentsmaneuvermaneuvermaneuvermaneuverhemangiomahematologyhematologyhematologyhematologyhematemesishematocrithematocrithematocrithematuriahemihypertrophyhemiplegia